Cytokinetics (CYTK) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Cytokinetics (CYTK) over the last 16 years, with Q3 2024 value amounting to -$76.3 million.
- Cytokinetics' Other Gross PP&E Adjustments rose 448.52% to -$76.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$76.3 million, marking a year-over-year increase of 448.52%. This contributed to the annual value of $18.1 million for FY2023, which is 2227.55% up from last year.
- As of Q3 2024, Cytokinetics' Other Gross PP&E Adjustments stood at -$76.3 million, which was up 448.52% from -$77.2 million recorded in Q2 2024.
- Over the past 5 years, Cytokinetics' Other Gross PP&E Adjustments peaked at $35.1 million during Q4 2020, and registered a low of -$83.0 million during Q2 2021.
- For the 5-year period, Cytokinetics' Other Gross PP&E Adjustments averaged around -$53.2 million, with its median value being -$76.8 million (2024).
- Per our database at Business Quant, Cytokinetics' Other Gross PP&E Adjustments crashed by 5344.95% in 2021 and then surged by 2227.55% in 2023.
- Cytokinetics' Other Gross PP&E Adjustments (Quarter) stood at $35.1 million in 2020, then tumbled by 53.45% to $16.3 million in 2021, then dropped by 9.26% to $14.8 million in 2022, then increased by 22.28% to $18.1 million in 2023, then tumbled by 521.58% to -$76.3 million in 2024.
- Its Other Gross PP&E Adjustments stands at -$76.3 million for Q3 2024, versus -$77.2 million for Q2 2024 and -$78.2 million for Q1 2024.